Cargando…

Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody–associated disease: a systematic review and meta-analysis

BACKGROUND: A considerable number of patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) will experience a relapse, but the effect of maintenance therapies on re-attack rates is currently unknown. OBJECTIVE: To investigate the efficacy and safety of immunosuppressiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Qi-Lun, Zhang, Yin-Xi, Cai, Meng-Ting, Zheng, Yang, Qiao, Song, Fang, Gao-Li, Shen, Chun-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591780/ https://www.ncbi.nlm.nih.gov/pubmed/34790259 http://dx.doi.org/10.1177/17562864211054157

Ejemplares similares

Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder Masquerading as Multiple Sclerosis: An Under-Recognized Entity?
por: Zheng, Yang, et al.
Publicado: (2021)

Immunosuppressive and monoclonal antibody treatment for myasthenia gravis: A network meta‐analysis
por: Wang, Liang, et al.
Publicado: (2019)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
por: Nakajima, Hideki, et al.
Publicado: (2015)

Limbic Encephalitis with Anti-myelin Oligodendrocyte Glycoprotein Antibody
por: Takasone, Ken, et al.
Publicado: (2020)

Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis
por: Li, Shaojun, et al.
Publicado: (2017)

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
por: Ramanathan, Sudarshini, et al.
Publicado: (2014)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
por: Tea, Fiona, et al.
Publicado: (2019)

Gray Matter Encephalomyelitis with Anti-Myelin Oligodendrocyte Glycoprotein Antibody
por: Morizumi, Teruya, et al.
Publicado: (2020)

Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated disease
por: Kim, Hyunjin, et al.
Publicado: (2020)

Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease with Frequent Cerebellitis
por: Ishikura, Teruyuki, et al.
Publicado: (2022)

The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway
por: Lerch, Magdalena, et al.
Publicado: (2023)

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
por: Perez-Giraldo, Gina, et al.
Publicado: (2023)

Astrocytoma with myelin oligodendrocyte glycoprotein antibody associated encephalomyelitis: A case report
por: Zhong, Guanghong, et al.
Publicado: (2022)

Efficacy and safety of intraperitoneal chemotherapy in patients with advanced gastric cancer: a cumulative meta-analysis of randomized controlled trials
por: He, Zheng, et al.
Publicado: (2017)

Comparative efficacy and safety of antibody induction therapy for the treatment of kidney: a network meta-analysis
por: Shao, Mingjie, et al.
Publicado: (2017)

The efficacy and safety of anti-PD-1/PD-L1 antibody therapy versus docetaxel for pretreated advanced NSCLC: a meta-analysis
por: Huang, Guanghong, et al.
Publicado: (2017)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Myelin Oligodendrocyte Glycoprotein Antibody Syndrome and Seizures: A Diagnostic Clue
por: Agarwal, Ayush, et al.
Publicado: (2022)

Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease
por: Ladakis, Dimitrios C, et al.
Publicado: (2022)

Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease
por: Valencia‐Sanchez, Cristina, et al.
Publicado: (2022)

New-onset epilepsy in a patient with myelin oligodendrocyte glycoprotein antibodies
por: Im, Hansol, et al.
Publicado: (2021)

Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
por: Lipps, Patrick, et al.
Publicado: (2023)

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease and an Incidental Thyroid Nodule
por: Henriquez, C. J., et al.
Publicado: (2023)

Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein antibody levels associate with different disease courses of myelin oligodendrocyte glycoprotein-associated disease in children
por: Horellou, Philippe, et al.
Publicado: (2023)

Efficacy and safety of monoclonal antibodies in neuromyelitis optica spectrum disorders: A survival meta-analysis of randomized controlled trials
por: Xu, Xintong, et al.
Publicado: (2022)

The Relationship between Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and the Rubella Virus
por: Choi, Seok-Jin, et al.
Publicado: (2018)

Safety and clinical efficacy of linezolid in children: a systematic review and meta-analysis
por: Shi, Yi, et al.
Publicado: (2022)

Efficacy and Safety of Acupuncture for Essential Hypertension: A Meta-Analysis
por: Chen, Hao, et al.
Publicado: (2018)

Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis
por: Li, Mingxia, et al.
Publicado: (2019)

Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
por: Wu, Mei-Yi, et al.
Publicado: (2017)

Efficacy and safety of argatroban in treatment of acute ischemic stroke: A meta-analysis
por: Lv, Bin, et al.
Publicado: (2022)

Efficacy and safety of daratumumab in the treatment of multiple myeloma: a systematic review and meta-analysis
por: Wang, Yin, et al.
Publicado: (2021)

The safety of ceftolozane-tazobactam for the treatment of acute bacterial infections: a systemic review and meta-analysis
por: Wang, Li-Ting, et al.
Publicado: (2021)

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Qiao, Shu-Kai, et al.
Publicado: (2015)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
por: Mader, Simone, et al.
Publicado: (2011)

Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
por: Hacohen, Yael, et al.
Publicado: (2015)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g5kj8djfq5kkpeb2iu820j0rjt